-
-
-
-
-
-
-
Erste Group Upgrades Abbvie (ABBV) to Buy
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $300 at BMO Capital
-
-
-
-
-
-
-
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
-
-
-
-
-
-
-
Barclays launches U.S. biopharma coverage with four preferred picks
-
-
-
-
-
-
-
West to sell SmartDose 3.5mL manufacturing rights to AbbVie for $112.5M
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $225 at Bernstein SocGen Group
-
-
-
-
-
-
-
Erste Group Downgrades Abbvie (ABBV) to Hold
-
1,227,475 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

